Mi SciELO
Servicios Personalizados
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista Cubana de Hematología, Inmunología y Hemoterapia
versión On-line ISSN 1561-2996
Resumen
LAVAUT SANCHEZ, Kalia y GONZALEZ GARCIA, Sheila. Cytogenetic and molecular aspects in myelodysplastic syndromes. Rev Cubana Hematol Inmunol Hemoter [online]. 2022, vol.38, n.2 Epub 01-Jun-2022. ISSN 1561-2996.
Introduction:
Myelodysplastic syndromes constitute a heterogeneous group of alterations of the hematopoietic progenitor cell, characterized by hypercellular bone marrow, ineffective hematopoietic, dysplasia and peripheral cytopenia; and the possibility of progressing to acute myeloid leukemia.
Objective:
To describe the most frequent cytogenetic and molecular alterations of myelodysplastic syndromes.
Methods:
A review of the literature in English and in Spanish was carried out, in the PubMed website and using the search engine Google, for articles published in the last five years. We performed analysis and summary of the reviewed bibliography.
Analysis and synthesis of information:
In myelodysplastic syndromes, frequent cytogenetic alterations are present such as deletion of chromosomes 5q, 7q and 20q, as well as the monosomy of chromosome 7, trisomy of chromosome 8 and the presence of complex karyotypes, which together with somatic mutations in different genes intervene in the pathogenesis of the disease and allow prognostic stratification of patients.
Conclusions:
Diagnosis through conventional cytogenetic studies, fluorescence in situ hybridization and gene sequencing allow a better understanding of the biology of the disease, risk stratification and therapeutic decision making.
Palabras clave : myelodysplastic syndrome; chromosomal abnormalities; somatic mutations; germline mutations.